Alkermes plc [ALKS] vs Elanco Animal Health [ELAN] Detailed Stock Comparison
Alkermes plc
NASDAQ
Loading...
Elanco Animal Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Alkermes plc wins in 15 metrics, Elanco Animal Health wins in 4 metrics, with 0 ties. Alkermes plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alkermes plc | Elanco Animal Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.03 | 20.41 | Alkermes plc |
| Price-to-Book Ratio | 2.95 | 1.32 | Elanco Animal Health |
| Debt-to-Equity Ratio | 4.47 | 62.13 | Alkermes plc |
| PEG Ratio | -7.58 | -0.17 | Alkermes plc |
| EV/EBITDA | 9.55 | 14.96 | Alkermes plc |
| Profit Margin (TTM) | 23.15% | 9.68% | Alkermes plc |
| Operating Margin (TTM) | 23.80% | 6.85% | Alkermes plc |
| EBITDA Margin (TTM) | 23.80% | 6.85% | Alkermes plc |
| Return on Equity | 23.94% | 6.83% | Alkermes plc |
| Return on Assets (TTM) | 10.49% | 0.98% | Alkermes plc |
| Free Cash Flow (TTM) | $405.64M | $380.00M | Alkermes plc |
| 1-Year Return | 6.61% | 23.95% | Elanco Animal Health |
| Price-to-Sales Ratio (TTM) | 3.19 | 1.99 | Elanco Animal Health |
| Enterprise Value | $3.85B | $12.59B | Elanco Animal Health |
| EV/Revenue Ratio | 2.56 | 2.81 | Alkermes plc |
| Gross Profit Margin (TTM) | 87.34% | 57.45% | Alkermes plc |
| Revenue per Share (TTM) | $9 | $9 | Alkermes plc |
| Earnings per Share (Diluted) | $2.07 | $0.88 | Alkermes plc |
| Beta (Stock Volatility) | 0.43 | 1.66 | Alkermes plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Alkermes plc vs Elanco Animal Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alkermes plc | 2.80% | 8.76% | 0.69% | -6.92% | -19.08% | 1.04% |
| Elanco Animal Health | -0.22% | 7.74% | 22.93% | 38.79% | 58.66% | 49.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alkermes plc | 6.61% | 15.00% | 70.18% | -51.86% | 111.58% | 90.62% |
| Elanco Animal Health | 23.95% | 2.80% | -33.73% | -47.33% | -47.33% | -47.33% |
Performance & Financial Health Analysis: Alkermes plc vs Elanco Animal Health
| Metric | ALKS | ELAN |
|---|---|---|
| Market Information | ||
| Market Cap | $4.80B | $8.92B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,277,250 | 7,701,440 |
| 90 Day Avg. Volume | 1,927,183 | 5,590,757 |
| Last Close | $29.05 | $17.96 |
| 52 Week Range | $25.56 - $36.45 | $8.02 - $18.09 |
| % from 52W High | -20.30% | -0.72% |
| All-Time High | $98.50 (Feb 28, 2000) | $37.61 (Sep 24, 2018) |
| % from All-Time High | -70.51% | -52.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.05% |
| Quarterly Earnings Growth | -0.05% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.23% | 0.10% |
| Operating Margin (TTM) | 0.24% | 0.07% |
| Return on Equity (TTM) | 0.24% | 0.07% |
| Debt to Equity (MRQ) | 4.47 | 62.13 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.84 | $13.64 |
| Cash per Share (MRQ) | $6.15 | $1.09 |
| Operating Cash Flow (TTM) | $521.00M | $572.00M |
| Levered Free Cash Flow (TTM) | $345.67M | $1.21B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Alkermes plc vs Elanco Animal Health
| Metric | ALKS | ELAN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.03 | 20.41 |
| Forward P/E | 14.45 | 19.11 |
| PEG Ratio | -7.58 | -0.17 |
| Price to Sales (TTM) | 3.19 | 1.99 |
| Price to Book (MRQ) | 2.95 | 1.32 |
| Market Capitalization | ||
| Market Capitalization | $4.80B | $8.92B |
| Enterprise Value | $3.85B | $12.59B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.56 | 2.81 |
| Enterprise to EBITDA | 9.55 | 14.96 |
| Risk & Other Metrics | ||
| Beta | 0.43 | 1.66 |
| Book Value per Share (MRQ) | $9.84 | $13.64 |
Financial Statements Comparison: Alkermes plc vs Elanco Animal Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALKS | ELAN |
|---|---|---|
| Revenue/Sales | $306.51M | $1.19B |
| Cost of Goods Sold | $49.20M | $509.00M |
| Gross Profit | $257.31M | $684.00M |
| Research & Development | $71.82M | $94.00M |
| Operating Income (EBIT) | $13.79M | $121.00M |
| EBITDA | $32.91M | $270.00M |
| Pre-Tax Income | $25.49M | $60.00M |
| Income Tax | $3.03M | $-7.00M |
| Net Income (Profit) | $22.46M | $67.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALKS | ELAN |
|---|---|---|
| Cash & Equivalents | $399.81M | $487.00M |
| Total Current Assets | $1.48B | $3.44B |
| Total Current Liabilities | $443.73M | $1.27B |
| Long-Term Debt | $67.81M | $4.35B |
| Total Shareholders Equity | $1.51B | $6.35B |
| Retained Earnings | $-953.99M | $-1.88B |
| Property, Plant & Equipment | $82.41M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALKS | ELAN |
|---|---|---|
| Operating Cash Flow | $122.31M | $-4.00M |
| Capital Expenditures | $-8.40M | $-65.00M |
| Free Cash Flow | $88.70M | $-69.00M |
| Debt Repayment | $0 | $-178.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALKS | ELAN |
|---|---|---|
| Shares Short | 13.82M | 23.96M |
| Short Ratio | 6.35 | 5.44 |
| Short % of Float | 0.12% | 0.07% |
| Average Daily Volume (10 Day) | 1,277,250 | 7,701,440 |
| Average Daily Volume (90 Day) | 1,927,183 | 5,590,757 |
| Shares Outstanding | 162.18M | 494.45M |
| Float Shares | 162.42M | 493.03M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.05% | 1.09% |
Dividend Analysis & Yield Comparison: Alkermes plc vs Elanco Animal Health
| Metric | ALKS | ELAN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |